A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
Bayer
Bayer
National Cancer Institute (NCI)
Fate Therapeutics
Alterome Therapeutics, Inc.
Hoffmann-La Roche
Erasca, Inc.
Incyte Corporation
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
BeOne Medicines
AstraZeneca
Incyte Corporation
Eli Lilly and Company
Pfizer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Pfizer
Tizona Therapeutics, Inc
Genentech, Inc.
Revolution Medicines, Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Pfizer
PAQ Therapeutics, Inc.
Eli Lilly and Company
Bristol-Myers Squibb
Genentech, Inc.
M.D. Anderson Cancer Center
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Kumquat Biosciences Inc.
Pfizer
Ono Pharmaceutical Co. Ltd
Shanghai Zhongshan Hospital
Fate Therapeutics
Massachusetts General Hospital
Eli Lilly and Company
Innovent Biologics (Suzhou) Co. Ltd.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
West China Hospital
Curegenix Inc.
Fate Therapeutics
Eli Lilly and Company
National Cancer Institute (NCI)
Lund University Hospital
National Institutes of Health Clinical Center (CC)
Dragonboat Biopharmaceutical Company Limited
M.D. Anderson Cancer Center
Georgetown University
Novartis
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.